40 mg
Sponsors
Region Skane, Region Skane, Turku University Hospital, Medical University Of Bialystok, Instytut Hematologii I Transfuzjologii
Conditions
Bladder cancerChronic obstructive pulmonary disease (COPD)Diffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCLDiffuse large B-cell lymphomas (DLBCLHigh-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiationPrimary or recurrent non-muscle invasive bladder cancer with intermediate risk of recurrence after transurethral tumour resection
Phase 2
Phase 3
Adjuvant instillations in intermediate risk NMIBC: A Study comparIng Gemcitabine and MitomYciN (SIGYN-trial)
Active, not recruitingCTIS2023-504945-30-00
Start: 2021-03-16Target: 340Updated: 2024-08-30
Intravesical instillation therapy with bacillus Calmette-Guérin (BCG) and sequential BCG and electromotive mitomycin-C (EMDA-MMC) in patients with high-risk non-muscle-invasive bladder carcinoma (FINNBLADDER 10)
RecruitingCTIS2024-516320-33-00
Start: 2019-01-07Target: 300Updated: 2024-09-19
Non-commercial clinical trial of statins CAncer preventive and Pleiotropic TherApy IN smokers with chronic obstructive pulmonary disease (COPD)
Clinical part: Atorvastatin effect on reduction of COPD exacerbations.
Genomic part: Assessment of immunobiology of COPD related lung carcinoma and inflammatory pathways activation based on gene expression profiles of the peripheral blood leukocytes (PBLs) and peripheral blood mononuclear cells (PBMCs) from smokers with chronic obstructive pulmonary disease (COPD).
RecruitingCTIS2024-516714-37-00
Start: 2022-01-19Target: 480Updated: 2024-12-02